Diabetic Eye Disease ViewpointCarl Zeiss Case StudiesRetina in 2020

Cataract & RefractiveCorneaGene TherapyGlaucomaInflammation & InfectionPaediatricsRetina

Medical World NewsPodcastsViewpoints

CME/CESponsored ResourcesZeiss Case Studies

eNewsletterPrint Subscription

Advertise
Editorial Info
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Information

© 2021 MJH Life Sciences and Opthalmology Times Europe. All rights reserved.

Spotlight

Diabetic Eye Disease Viewpoint
Carl Zeiss Case Studies
Retina in 2020

ClinicalSee All >

Cataract & Refractive
Cornea
Gene Therapy
Glaucoma
Inflammation & Infection
Paediatrics
Retina

Advertise
Editorial Info
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Information

© 2021 MJH Life Sciences^™ and Opthalmology Times Europe. All rights reserved.

FDA grants orphan status to two Lux products

March 1, 2007

The FDA has granted orphan drug designation to two of Lux Bioscience's investigational therapies.